3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
26
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms by Site
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Diseases
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Melanoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Genetic Diseases, Inborn
1
Fallopian Tube Neoplasms
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Lobular
1
Interventions
Oxaliplatin
9
Leucovorin
8
Fluorouracil
8
Cetuximab
6
Bevacizumab
5
Specimen Handling
4
Pemetrexed
4
pembrolizumab
3
fludarabine
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
Cisplatin
3
Carboplatin
3
encorafenib
2
dehydroftorafur
2
aldesleukin
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Disulfides
2
Celecoxib
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
temsirolimus
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Fulvestrant
×
30 days
×
Clear all
No trials found.